Symmetric Dimethylarginine is Altered in Patients After Myocardial Infarction and Predicts Adverse Outcomes

Symmetric Dimethylarginine is Altered in Patients After Myocardial Infarction and Predicts Adverse Outcomes

Aleksandra Gąsecka,1 Piotr Szwed,1 Karolina Jasińska,1 Oliwia Fidali,1 Aleksandra Kłębukowska,1 Ceren Eyileten,2 Marek Postula,2 Łukasz Szarpak,3,4 Tomasz Mazurek,1 Grzegorz Opolski,1 Krzysztof J Filipiak,1 Marcin Ufnal5 1 1st Chair and Department...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Gąsecka A, Szwed P, Jasińska K, Fidali O, Kłębukowska A, Eyileten C, Postula M, Szarpak Ł, Mazurek T, Opolski G, Filipiak KJ, Ufnal M
Format: article
Langue:EN
Publié: Dove Medical Press 2021
Sujets:
nitric oxide
l-arginine
acute myocardial infarction
major adverse cardiovascular events
prognosis
Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
Accès en ligne:https://doaj.org/article/2e5d2715bf7047f8b06aab171ed65a01
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/2e5d2715bf7047f8b06aab171ed65a01

Documents similaires